Repositioning Candidate Details

Candidate ID: R0497
Source ID: DB01342
Source Type: experimental
Compound Type: small molecule
Compound Name: Forasartan
Synonyms: Forasartan
Molecular Formula: C23H28N8
SMILES: CCCCC1=NN(CC2=CN=C(C=C2)C2=CC=CC=C2C2=NNN=N2)C(CCCC)=N1
Structure:
DrugBank Description: Forasartan, a specific angiotensin II antagonist, is used alone or with other antihypertensive agents to treat hypertension. Forasartan competes with angiotensin II for binding at the AT1 receptor subtype. As angiotensin II is a vasoconstrictor which also stimulates the synthesis and release of aldosterone, blockage of its effects results in a decreases in systemic vascular resistance.
CAS Number: 145216-43-9
Molecular Weight: 416.522
DrugBank Indication: For the treatment of hypertension.
DrugBank Pharmacology: Forasartan, a specific angiotensin II antagonist, is used alone or with other antihypertensive agents to treat hypertension. By inhibiting angiotensin II receptors, this drug leads to a decrease in sodium reabsorption (which decreases water content of blood) and a decrease in vasoconstriction. Combined, this has the effect of lowering blood pressure.
DrugBank MoA: Forasartan competes with angiotensin II for binding at the AT<sub>1</sub> receptor subtype. As angiotensin II is a vasoconstrictor which also stimulates the synthesis and release of aldosterone, blockage of its effects results in a decreases in systemic vascular resistance. Also, since angiotensin causes vasoconstriction, the inhibition of this receptor decreases vasoconstriction, which consequently also decreases vascular resistnace.
Targets: Type-1 angiotensin II receptor antagonist
Inclusion Criteria: Target associated